抗血管生成疗法:癌症的通用化学敏感化策略?
1Sunnybrook Health Sciences Centre, Departments of Medical Biophysics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M4N 3M5, Canada. robert.kerbel@sri.utoronto.ca
某些抗血管原药在癌症治疗中表现有前途,因为它们使癌细胞对化疗更敏感. 这些药物通过使瘤血管正常化,减缓癌细胞生长,增强化疗作用来起作用.
科学领域:
- 在瘤学瘤学.
- 癌症治疗方法 癌症治疗方法
- 药物开发 药物开发
背景情况:
- 癌症研究的一个长期目标是找到能够增强化疗有效性的药物,而不会增加副作用.
- 最近的临床试验表明,抗血管生成药物可以实现这一目标.
研究的目的:
- 解释抗血管生成药物使癌细胞对化疗敏感的机制.
- 讨论优化这些药物的治疗用途的策略.
主要方法:
- 对抗血管新生药物和化疗的现有研究和临床试验数据的审查.
- 对拟议的生物作用机制的分析.
主要成果:
- 抗血管性药物可以通过三个主要机制使瘤变得化学敏感:使瘤血管正常化,抑制瘤细胞的快速再生,并强化化疗的抗血管作用.
- 这些机制为改善癌症治疗疗效提供了潜在的途径.
结论:
- 抗血管新生药物代表了增强细胞毒性化疗的有希望的战略.
- 了解和利用这些机制可以导致更有效的癌症治疗方案.
更多相关视频
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
相关概念视频
Cancer
The Tumor Microenvironment
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
